Clinical Trial

A Trial to Evaluate Safety and Efficacy of a Product Named VGN-R09b in Patients With Parkinson's Disease

Active, Not Recruiting Phase 1/2
View on ClinicalTrials.gov →
Summary
A phase Ⅰ/Ⅱ study to evaluate the tolerability, safety, and efficacy of VGN-R09b in pa-tients with Parkinson's disease
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2024-06-24.
Status change: Not Yet Recruiting → Active, Not Recruiting 2026-03-30
Trial Details
NCT Number NCT06480461
Lead Sponsor Shanghai Vitalgen BioPharma Co., Ltd.
Conditions Parkinson's Disease
Enrollment 39 participants
Start Date 2024-09-02
Primary Completion 2026-09-10 (estimated)
Study Completion 2030-09-10 (estimated)
Updated on ClinicalTrials.gov 2026-03-31